 




<DOCTITLE>Availability of Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patent Application Concerning
a CS6 Antigen for Use in Vaccines</DOCTITLE>



<AGENCY>
AGENCY: 

U.S. Army Medical Research and Materiel Command, DOD.



</AGENCY>
<ACTION>
ACTION: 

Notice of availability.






</ACTION>
<SUMMARY>
SUMMARY: 

In accordance with 37 CFR 404.7(a)(1)(i), announcement is made of the availability of U.S. Patent Application SN
08/243,482, entitled ``Transformed Bacteria Producing CS6 Antigens as Vaccines'', and filed May 13, 1994, for licensing.
This patent has been assigned to the United States Government as represented by the Secretary of the Army.



</SUMMARY>
<ADDRESS>
ADDRESSES: 

Commander, U.S. Army Medical Research and Materiel Command, ATTN: Staff Judge Advocate, Fort Detrick, Frederick,
Maryland 217025012.



</ADDRESS>
<FURTHER>
FOR FURTHER INFORMATION CONTACT: 

Mr. John F. Moran, Patent Attorney, (301) 6192065 or telefax (301) 6197714.



</FURTHER>
<SUPPLEM>
SUPPLEMENTARY INFORMATION: 

This invention relates to the definition of structural proteins which will act as antigens to stimulate protective
immunity against enterotoxigenic 

Escherichia coli.

 Particularly significant are the proteins having the antigenic properties of the proteins encoded by the 

cssA

 and 

cssB

 genes. Constructs may be prepared with encode either one or both of the proteins. 

cssA

 and 

cssB

 encode the structural proteins of CS6. The invention further describes composition of matter and methods wherein
a bacteria transformed with a plasmid which contains the genes 

cssA

 and 

cssB.




</SUPPLEM>
<SIGNER>
Kenneth L. Denton,

</SIGNER>
<SIGNJOB>
Army Federal Register Liaison Officer.


</SIGNJOB>
<FRFILING>
[FR Doc. 9426774 Filed 102794; 8:45 am]

</FRFILING>
<BILLING>
BILLING CODE 371008M
</BILLING>




